People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

While some of these tumors may produce hormones, the tumor in this case was non-functional and was discovered only through microscopic analysis after removal during surgery for an unrelated condition.

While some of these tumors may produce hormones, the tumor in this case was non-functional and was discovered only through microscopic analysis after removal during surgery for an unrelated condition.

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain ...

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian cancer.

Ovarian cysts are fluid-filled sacs that form on or inside the ovaries for a variety of reasons. Often, they disappear on ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer.

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type of ovarian cancer in a late-stage trial.

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory agencies.

Hormone therapy for breast cancer slows or stops the growth of hormone-sensitive tumors and is not the same as hormone replacement therapy.